Citation

81 FR 31251

Multiple canonical documents share this first-page citation.

Prospective Grant of an Exclusive License: The Development of an Anti-GPC3 Chimeric Antigen Receptor (CAR) Based on YP7 for the Treatment of Human Cancers Wednesday, May 18, 2016 81 FR 31251
National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Wednesday, May 18, 2016 81 FR 31251